Early stage trials of the vaccine candidate, BBV154, has been completed in subjects aged 18 to 60 years, and the doses were found to be well tolerated
from Current Affairs https://ift.tt/3sh7FNm
from Current Affairs https://ift.tt/3sh7FNm
Bharat Biotech's nasal Covid-19 vaccine advances into next stage of trials
![Bharat Biotech's nasal Covid-19 vaccine advances into next stage of trials]()
Reviewed by শ্রী শ্রী সত্যনারায়ণ নমঃ
on
August 14, 2021
Rating:
No comments: